People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds

Advertisement

Advertise with us

People taking the popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions, a new federal study finds.

Read this article for free:


or

Already have an account? Log in here »

To continue reading, please subscribe:

Subscribe and receive a limited-edition Free Press branded hat or tote.

Digital Subscription

One year of digital access for only $205*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles

*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.

To continue reading, please subscribe:

Add Free Press access to your Brandon Sun subscription for only an additional

$1 for the first 4 weeks*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles
Start now

*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.

Hey there, time traveller!
This article was published 05/01/2024 (1001 days ago), so information in it may no longer be current.

People taking the popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions, a new federal study finds.

The research, funded by the National Institutes of Health, was published Friday and comes as European and U.S. regulators look into anecdotal reports that people taking the drug, semaglutide, had thoughts of self-harm.

NIH and Case Western Reserve University researchers analyzed electronic medical records from more than 1.8 million patients prescribed semaglutide or another drug to treat obesity or diabetes between 2017 and 2022. They included about 240,000 patients treated for obesity or being overweight and nearly 1.6 million patients treated for diabetes.

FILE - This image provided by Novo Nordisk on Friday, June 4, 2021 shows a package of injection pens for the company's semaglutide medication, named Wegovy. People taking the popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions, according to research, funded by the U.S. National Institutes of Health, published Friday, Jan. 5, 2023. It comes as European and U.S. regulators look into anecdotal reports that people taking the drug, semaglutide, had thoughts of self-harm. (Novo Nordisk via AP, file)
FILE - This image provided by Novo Nordisk on Friday, June 4, 2021 shows a package of injection pens for the company's semaglutide medication, named Wegovy. People taking the popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions, according to research, funded by the U.S. National Institutes of Health, published Friday, Jan. 5, 2023. It comes as European and U.S. regulators look into anecdotal reports that people taking the drug, semaglutide, had thoughts of self-harm. (Novo Nordisk via AP, file)

They found that people taking semaglutide had a 49% to 73% lower risk of first-time or recurring suicidal thoughts than those taking another drug for those conditions during a six-month follow-up period.

The researchers called for closer evaluation of reports of suicidal thoughts linked to the drugs and for patients to be followed for a longer period of time. Their review only considered patients taking semaglutide or another drug for diabetes or obesity, not those taking semaglutide in the general population.

Study co-author Dr. Rong Xu, of Case Western, also noted obesity and diabetes are risk factors on their own for suicidal thoughts. But the study wasn’t designed to determine if the GLP-1 drugs reduced those thoughts.

The scientists launched the review after the European Medicines Agency said in July that it was reviewing about 150 reports of possible cases of self-injury and suicidal thoughts linked to semaglutide and other drugs known as GLP-1 receptor agonists. The drugs work by targeting the hormones in the gut and brain that regulate appetite and feelings of fullness. Older weight-loss drugs work differently.

In December, the EMA’s drug watchdog group said it would seek more data from drugmaker Novo Nordisk about the reports.

The U.S. Food and Drug Administration also is investigating unconfirmed reports of suicidal thoughts or actions in people taking the GLP-1 drugs.

Millions of people in the U.S. are taking semaglutide, which has soared in popularity since Wegovy was approved to treat obesity in June 2021.

A spokesperson for Novo Nordisk said the new study reflects the company’s data collected from large clinical trials and since the drug has been on the market — all of which showed no “causal association” between semaglutide and thoughts of suicide or self-harm.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Report Error Submit a Tip

More Stories

People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds

Jonel Aleccia, The Associated Press 3 minute read Preview

People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds

Jonel Aleccia, The Associated Press 3 minute read Friday, Jan. 5, 2024

People taking the popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions, a new federal study finds.

The research, funded by the National Institutes of Health, was published Friday and comes as European and U.S. regulators look into anecdotal reports that people taking the drug, semaglutide, had thoughts of self-harm.

NIH and Case Western Reserve University researchers analyzed electronic medical records from more than 1.8 million patients prescribed semaglutide or another drug to treat obesity or diabetes between 2017 and 2022. They included about 240,000 patients treated for obesity or being overweight and nearly 1.6 million patients treated for diabetes.

They found that people taking semaglutide had a 49% to 73% lower risk of first-time or recurring suicidal thoughts than those taking another drug for those conditions during a six-month follow-up period.

Read
Friday, Jan. 5, 2024

J’accuse!: Kinew uses French to fry interim Tory leader over alleged caucus subterfuge

Chris Kitching and Maggie Macintosh 4 minute read Preview

J’accuse!: Kinew uses French to fry interim Tory leader over alleged caucus subterfuge

Chris Kitching and Maggie Macintosh 4 minute read Yesterday at 5:55 PM CDT

NDP Premier Wab Kinew took a dig at the Progressive Conservatives’ leadership change while facing off with Obby Khan’s short-term replacement for the first time in question period Thursday.

Read
Yesterday at 5:55 PM CDT

Clock ticks down on destruction of records documenting residential school abuses

Marsha McLeod 13 minute read Preview

Clock ticks down on destruction of records documenting residential school abuses

Marsha McLeod 13 minute read 12:49 PM CDT

In less than a year, a private company is set to destroy the largest cache of records detailing the widespread abuse of Indigenous children at residential schools in Canada.

The destruction, which was ordered by an Ontario court in 2014 and later upheld by the Supreme Court, is set to take place on Sept. 19, 2027.

This countdown is igniting emotional conversations that seek to balance the immense historical value of the records alongside the confidentiality survivors were promised as part of the process of providing detailed testimony about abuses they’d suffered.

The records were created as part of the Indian Residential Schools Settlement Agreement, a class-action settlement stemming from survivors who began suing the federal government in the late 1990s over the harm they’d been subjected to at residential schools.

Read
12:49 PM CDT

Jets new backup Stevenson ‘stoked’ to be in tandem with Skinner

Mike McIntyre 6 minute read Preview

Jets new backup Stevenson ‘stoked’ to be in tandem with Skinner

Mike McIntyre 6 minute read Wednesday, Sep. 30, 2026

It didn’t take long to get the dirt on the newest member of the Winnipeg Jets.

Meet Clay Stevenson, who has no problem if you prefer to refer to him by his long-standing nickname of “Mud.”

“You know, Clay is in the mud, and there you go. That’s it, right there,” Stevenson said Wednesday with a laugh. “I got it in juniors when I was playing in Coquitlam, and kind of stuck ever since.”

Stevenson is now hoping to make a name for himself in a city that, quite fittingly, translates to “muddy water” in Cree. The 27-year-old from Alberta was placed on waivers by the Washington Capitals and claimed by the Jets, who were looking to clarify a goaltending situation which was as murky as the Red River.

Read
Wednesday, Sep. 30, 2026

Listen up

3 minute read 3:00 PM CDT

Listen to Laura June RoseWritten while moving from Vancouver to Winnipeg, the four songs on Laura June Rose’s debut EP Passages — released this week for free or with a donation on her Bandcamp — is a retrospective roadmap that tracks a songwriter finding her way back and forward.

“I view the four songs and stories on this album as ‘passages’ in many senses of the word,” writes Rose, who also plays drums with the O.D. Beresford band.

“They are a way of exit from the punk and rock ’n’ roll subcultures that I grew up (with) in Calgary, Alberta, and Vancouver, British Columbia, as well as a way of entrance into the American folk revival, outlaw country, and contemporary Celtic traditional movements,” Rose writes. “They move through different geographical locations, psychological and spiritual conditions, and stages of my early adulthood.”

The first track, titled Winnipeg, sees Rose “in the village,” finding “a hole with a lonesome sound” in a pub on Osborne Street. “And the room was empty — almost no one around,” Rose drawls. “But he played the songs I knew.”

Man who killed two Indigenous women, was accused of killing third, back in prison less than year after statutory release

Erik Pindera 4 minute read Preview

Man who killed two Indigenous women, was accused of killing third, back in prison less than year after statutory release

Erik Pindera 4 minute read Yesterday at 4:06 PM CDT

A Winnipeg man convicted of killing two First Nations women more than a decade ago — with charges stayed in a third slaying — has been sent back to prison less than a year after he left under conditions.

Parole Board of Canada officials revoked 67-year-old Shawn Lamb’s statutory release after a hearing last week.

“Your actions are not beyond your control, yet you continue to wilfully make poor decisions that place the public at risk,” board member Arun Kundu-Thomsen wrote in a decision released this week.

Lamb gained statutory release — a legislated conditional release most federal inmates automatically qualify for after serving two-thirds of their sentence — in November last year and lived in several Ontario facilities for federal offenders.

Read
Yesterday at 4:06 PM CDT